Brian DeGuzman Net Worth

Brian DeGuzman biography

Dr. Brian J. DeGuzman M.D. serves as Executive Vice President - Clinical Affairs, Chief Medical Officer of the Company. Dr. deGuzman has served as a co-founding Partner of Pavilion Holdings Group and Pavilion Medical Innovations since their respective inceptions in 2007 and 2009. Dr. deGuzman was the President and Chief Executive Officer of Kaleidoscope Medical that was founded in 2013 and has also served as a Senior Advisor to PMI portfolio companies Saphena Medical since February 2013 and Cruzar Medsystems since July 2013. Dr. deGuzman served as Chief Medical Officer of Vortex Medical from inception until its sale to AngioDynamics in 2012. During his surgical career, Dr. deGuzman was a consultant to various medical device companies, including Edward Lifesciences, AngioDynamics, Zimmer-Biomet and Atricure, and served on the Revascularization Scientific Advisory Board of Maquet Cardiovascular (formerly Boston Scientific and Guidant Cardiac Surgery). Prior to moving into the medical device industry full-time in 2012, Dr. deGuzman was Assistant Professor of Surgery, Associate Chief of Cardiovascular Surgery, and Surgical Director of the Atrial Fibrillation Clinic and Cardiothoracic Surgical Intensive Care Unit at St. Joseph’s Hospital and Medical Center’s Heart and Lung Institute from 2006 to 2012. From 2002 to 2006, Dr. deGuzman was Assistant Professor of Surgery at Tufts University School of Medicine and an attending cardiac surgeon at the Lahey Clinic Medical Center in Massachusetts. From 2001 to 2002, Dr. deGuzman was a Clinical Associate of Cardiac Surgery at the Cleveland Clinic. Dr. deGuzman received his general surgical training at the University of Connecticut/Hartford Hospital, was a Research Fellow at Harvard Medical School’s Cardiac Surgery Research Laboratory and received his cardiothoracic surgical training at the University of Connecticut/Hartford Hospital.

What is the salary of Brian DeGuzman?

As the Executive Vice President - Clinical Affairs und Chief Medical Officer of PAVmed Inc, the total compensation of Brian DeGuzman at PAVmed Inc is $455,313. There are 4 executives at PAVmed Inc getting paid more, with Dr. Lishan Aklog M.D. having the highest compensation of $686,300.

How old is Brian DeGuzman?

Brian DeGuzman is 56, he's been the Executive Vice President - Clinical Affairs und Chief Medical Officer of PAVmed Inc since 2020. There are 5 older and 4 younger executives at PAVmed Inc. The oldest executive at PAVmed Inc is James Cox, 77, who is the Independent Director.

What's Brian DeGuzman's mailing address?

Brian's mailing address filed with the SEC is ONE GRAND CENTRAL PLACE, SUITE 4600, , NEW YORK, NY, 10165.

Insiders trading at PAVmed Inc

Over the last 9 years, insiders at PAVmed Inc have traded over $1,291,924 worth of PAVmed Inc stock and bought 370,262 units worth $523,987 . The most active insiders traders include Ira Scott Greenspan, Matthew Sirovich und Michael J Glennon. On average, PAVmed Inc executives and independent directors trade stock every 73 days with the average trade being worth of $62,625. The most recent stock trade was executed by Michael J Glennon on 5 December 2022, trading 250,000 units of PAVM stock currently worth $160,000.

What does PAVmed Inc do?

pavmed is a groundbreaking medical device company bringing innovative medical technologies from concept to commercialization with unprecedented speed and efficiency. led by three accomplished medical device entrepreneurs and organized to conceive, develop and commercialize a diversified pipeline of innovative products we believe address unmet clinical needs, our goal is to enhance and accelerate value creation by employing a business model focused on capital and time efficiency.

PAVmed Inc executives and stock owners

PAVmed Inc executives and other stock owners filed with the SEC include:

• Dr. Lishan Aklog M.D.,
  Chairman & CEO
• Lishan Aklog,
  Chairman of the Board, Chief Executive Officer
• Dennis M. McGrath CPA,
  Pres, CFO & Corp. Sec.
• Dennis McGrath,
  President, Chief Financial Officer and Corporate Secretary
• Brian DeGuzman,
  Executive Vice President - Clinical Affairs, Chief Medical Officer
• Dr. Brian J. deGuzman M.D.,
  Chief Medical Officer & Exec. VP of Clinical Affairs
• David Weild,
  Independent Director
• Ronald Sparks,
  Independent Director
• David Battleman,
  Independent Director
• James Cox,
  Independent Director
• Michael Glennon,
  Independent Vice Chairman of the Board
• Mike Havrilla,
  Director of Investor Relations
• Sunny Webb,
  VP, Data & Analytics
• James Mitchell M.D.,
  VP of Digital Health
• Shaun M. O'Neil,
  Chief Commercial Officer
• Ira Scott Greenspan,
  Director
• Joshua R Lamstein,
  Director
• Richard F Fitzgerald,
  CFO and Secretary
• Lishan Pavilion Venture Par...,
  Chairman and CEO
• Matthew Sirovich,
  10% owner
• Joan B Harvey,
  Director
• Shaun O'neil,
  Chief Operating Officer
• Debra White,
  Director
• Lishan Aklog,
  Chairman and CEO
• Timothy E Baxter,
  Director
• Michael Adam Gordon,
  General Counsel